Conclusion Higher cost-effectiveness ratio was found in aethoxysklerol group.
结论乙氧硬化醇组本益比高于鱼肝油酸钠组。
Selecting the right device for the right patient, with regards to the real clinical benefit and cost-effectiveness ratio.
根据真正的临床获益和风险效益比,为恰当的患者选择恰当的设备。
RESULTS: The cost-effectiveness ratio and incremental cost - effectiveness ratio of Esomeprazole were higher than those of omeprazole.
结果埃索美拉唑的成本、效果比和增长的成本、效果比均高于奥美拉唑。
应用推荐